Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most cases, be successfully treated with home remedies, over-the-counter ...

Over the past 15 years, Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products. CRISPR Therapeutics won its first regulatory ...

Ratings for Vertex VERX were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $502.55, marking a +0.45% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.33%.

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...

VX-264 Update Vertex has completed enrollment and dosing in Parts A and B of thePhase 1/2 VX-264 (cells + device) study and the planned analysis at Day 90 for Part B. In Part B of the study ...

In this episode, Barry chats with Vertex Minerals (ASX:VTX) executive chairman Roger Jackson, who is now making that pivotal switch to production from the Reward gold mine in the firing Lachlan ...

We've all been told time and again to massage our scalp with oil to get beautiful, luscious hair. Oil massaging is also said to thicken and strengthen our roots, reducing hair fall and promoting ...

Corinthia Black studies the anatomical features of fishes and spiders to understand how life on Earth takes shape ...